Publicaties
- pdf
Error in prostate-specific antigen levels after prostate cancer treatment with radical prostatectomy
Martens RJH, Ballieux BEPB, Bos R, Helmich F. Error in prostate-specific antigen levels after prostate cancer treatment with radical prostatectomy. Clin Chem Lab Med. 2025 May 29;63(10):e223-e226. doi: 10.1515/cclm-2025-0430. PMID: 40443083. - pdf
Regulating the future of laboratory medicine
Çubukçu HC, Boursier G, Linko S, Bernabeu-Andreu FA, Meško Brguljan P, Tosheska-Trajkovska K, Brugnoni D, Milinkovic N, Padoan A, Thelen M; European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Division: Quality, Standards and Regulations, Committee on Accreditation and ISO/CEN standards (C: A/ISO). Regulating the future of laboratory medicine: European regulatory landscape of AI-driven medical device software in laboratory medicine. Clin Chem Lab Med. 2025 May 28;63(10):1891-1914. doi: 10.1515/cclm-2025-0482. PMID: 40440607. - pdf
A proof-of-concept practical approach for achieving equivalent results from non-harmonized measurement methods while awaiting harmonization
Çubukçu HC, Zengi O, Alp HH, Cihan M, Uçar KT, Thelen M, Panteghini M. A proof-of-concept practical approach for achieving equivalent results from non-harmonized measurement methods while awaiting harmonization: The CA 125 example. Clin Chim Acta. 2025 Jul 15;575:120355. doi: 10.1016/j.cca.2025.120355. Epub 2025 May 15. PMID: 40381671. - pdf
IFCC recommendations for internal quality control practice a missed opportunity
Çubukçu HC, Thelen M, Plebani M, Panteghini M. IFCC recommendations for internal quality control practice: a missed opportunity. Clin Chem Lab Med. 2025 Apr 28;63(9):1693-1697. doi: 10.1515/cclm-2025-0486. PMID: 40287820. - pdf
Comments to the International Council for Standardization in Hematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls
Thelen MHM, van Schrojenstein Lantman M, Stavelin A, Loh TP. Comments to the International Council for Standardization in Hematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls. Semin Thromb Hemost. 2025 Apr 25. doi: 10.1055/a-2572-1299. Epub ahead of print. PMID: 40174876. - pdf
High sensitivity cardiac troponin assays, rapid myocardial infarction rule-out algorithms, and assay performance
Lackner KJ. High sensitivity cardiac troponin assays, rapid myocardial infarction rule-out algorithms, and assay performance. Clin Chem Lab Med. 2025 Jan 10;63(3):462-464. doi: 10.1515/cclm-2025-0013. PMID: 39786539. - pdf
Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA) Part I – EQA in general and EQA programs in particular
Buchta C, Marrington R, De la Salle B, Albarède S, Badrick T, Bietenbeck A, Bullock D, Cadamuro J, Delatour V, Dusinovic E, Geilenkeuser WJ, Gidske G, Griesmacher A, Haliassos A, Holzhauser D, Huggett JF, Karathanos S, Pezzati P, Sandberg S, Sarkar A, Solsvik AE, Spannagl M, Thelen M, Restelli V, Perrone LA. Behind the scenes of EQA - characteristics, capabilities, benefits and assets of external quality assessment (EQA). Clin Chem Lab Med. 2025 Jan 6. doi: 10.1515/cclm-2024-1289. Epub ahead of print. PMID: 39753377. - pdf
Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA) Part II – EQA cycles
Buchta C, Marrington R, De la Salle B, Albarède S, Badrick T, Berghäll H, Bullock D, Coucke W, Delatour V, Geilenkeuser WJ, Griesmacher A, Henriksen GM, Huggett JF, Luppa PB, Pelanti J, Pezzati P, Sandberg S, Spannagl M, Thelen M, Restelli V, Perrone LA. Behind the scenes of EQA - characteristics, capabilities, benefits and assets of external quality assessment (EQA). Clin Chem Lab Med. 2025 Jan 6. doi: 10.1515/cclm-2024-1290. Epub ahead of print. PMID: 39753241. - pdf
Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA) Part III – EQA samples
Buchta C, Marrington R, De la Salle B, Albarède S, Albe X, Badrick T, Berghäll H, Bullock D, Cobbaert CM, Coucke W, Delatour V, Geilenkeuser WJ, Griesmacher A, Henriksen GM, Huggett JF, Juhos I, Kammel M, Luppa PB, Meijer P, Pelanti J, Pezzati P, Sandberg S, Spannagl M, Thelen M, Thomas A, Zeichhardt H, Restelli V, Perrone LA. Behind the scenes of EQA - characteristics, capabilities, benefits and assets of external quality assessment (EQA). Clin Chem Lab Med. 2025 Jan 6. doi: 10.1515/cclm-2024-1291. Epub ahead of print. PMID: 39753204. - pdf
Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA) Part IV - Benefits for participant laboratories
Buchta C, De la Salle B, Marrington R, Albarède S, Badrick T, Bicker W, Bietenbeck A, Bullock D, Delatour V, Dequeker E, Flasch M, Geilenkeuser WJ, van Hellemond J, Huggett JF, Ianovska V, Kaiser P, Kammel M, Kessler A, Laudus N, Luppa PB, Morandi PA, O'Connor G, Panteghini M, Pezzati P, Rosendahl J, Sandberg S, Scheiblauer H, Skitek M, Spannagl M, Stavelin A, Thelen M, Unterberger U, Zeichhardt H, Restelli V, Perrone LA. Behind the scenes of EQA-characteristics, capabilities, benefits and assets of external quality assessment (EQA). Clin Chem Lab Med. 2025 Jan 6. doi: 10.1515/cclm-2024-1292. Epub ahead of print. PMID: 39754494.
2025